AGL vs. PINC, SHC, PGNY, CPRX, ATEC, SANA, BTSG, SNDX, FUSN, and SDGR
Should you be buying agilon health stock or one of its competitors? The main competitors of agilon health include Premier (PINC), Sotera Health (SHC), Progyny (PGNY), Catalyst Pharmaceuticals (CPRX), Alphatec (ATEC), Sana Biotechnology (SANA), BrightSpring Health Services (BTSG), Syndax Pharmaceuticals (SNDX), Fusion Pharmaceuticals (FUSN), and Schrödinger (SDGR). These companies are all part of the "medical" sector.
Premier (NASDAQ:PINC) and agilon health (NYSE:AGL) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings.
Premier has a net margin of 12.71% compared to Premier's net margin of -5.76%. agilon health's return on equity of 11.60% beat Premier's return on equity.
Premier has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, agilon health has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500.
74.4% of Premier shares are owned by institutional investors. 0.9% of Premier shares are owned by insiders. Comparatively, 3.6% of agilon health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, agilon health had 11 more articles in the media than Premier. MarketBeat recorded 18 mentions for agilon health and 7 mentions for Premier. agilon health's average media sentiment score of 0.38 beat Premier's score of 0.10 indicating that Premier is being referred to more favorably in the media.
Premier presently has a consensus target price of $25.15, indicating a potential upside of 20.45%. agilon health has a consensus target price of $9.46, indicating a potential upside of 85.57%. Given Premier's stronger consensus rating and higher probable upside, analysts clearly believe agilon health is more favorable than Premier.
Premier has higher earnings, but lower revenue than agilon health. agilon health is trading at a lower price-to-earnings ratio than Premier, indicating that it is currently the more affordable of the two stocks.
Premier received 562 more outperform votes than agilon health when rated by MarketBeat users. Likewise, 69.35% of users gave Premier an outperform vote while only 53.26% of users gave agilon health an outperform vote.
Summary
Premier beats agilon health on 11 of the 18 factors compared between the two stocks.
Get agilon health News Delivered to You Automatically
Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
agilon health Competitors List
Related Companies and Tools
